SUPERNUS PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (SUPN)

CUSIP: 868459108

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
57,572,193
Total 13F shares
48,465,165
Share change
-1,947,442
Total reported value
$871,862,986
Put/Call ratio
100%
Price per share
$17.99
Number of holders
199
Value change
-$52,617,228
Number of buys
84
Number of sells
132

Quarterly Holders Quick Answers

What is CUSIP 868459108?
CUSIP 868459108 identifies SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (SUPN) as of Q1 2020

As of 31 Mar 2020, SUPERNUS PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (SUPN) was held by 199 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 48,465,165 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, ARMISTICE CAPITAL, LLC, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, MACQUARIE GROUP LTD, MORGAN STANLEY, RICE HALL JAMES & ASSOCIATES, LLC, RENAISSANCE TECHNOLOGIES LLC, and Invesco Ltd.. This page lists 199 institutional shareholders reporting positions in this security for the Q1 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.